Buy Vytorin through the unique service that maximize your savings

WASHINGTON — A congressional committee investigating whether the marketers of the cholesterol drug Vytorin withheld data that would hurt sales has released new evidence that critics contend supports such suspicions. The Senate Finance Committee noted that even the researcher who led a crucial study of the drug accused Vytorin partners Merck & Co. and Schering-Plough Corp. of holding back negati…